RCPT Stock UPDATES Receptos Inc (RCPT) 95.76 10/28/2014 20:1

New Post Public Reply Private Reply Replies (0) Message Board

Oct 28, 2014 at 9:11 PM

Receptos Inc (RCPT) 95.76 $RCPT

Nasdaq stocks posting largest percentage increases
AP - 2 hrs 56 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
VDSI: 23.73 (+5.44), ECHO: 25.44 (-0.72), LAYN: 6.79 (-0.45), NVAX: 5.48 (-0.32), SCYX: 7.79 (+0.98), RCPT: 95.76 (+28.02), TRNX: 27.86 (+3.81), IDTI: 16.62 (+2.58), SANM: 24.50 (+5.14)

Twitter and Amgen are big market movers
AP - Tue Oct 28, 3:42PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
AMKR: 6.33 (-1.16), KSS: 54.66 (-3.89), MU: 32.61 (+0.31), PFE: 29.09 (+0.06), HAL: 53.26 (+0.87), AMGN: 157.19 (+8.99), NQ: 8.00 (-1.46), RGC: 21.28 (+0.77), MS: 34.36 (+0.40), MSG: 72.99 (+7.21), NVAX: 5.48 (-0.32), CQB: 14.39 (+0.03), SRPT: 15.12 (-0.79), RCPT: 95.76 (+28.02), TWTR: 43.78 (-4.78), PTIE: 2.07 (+0.12)

Health Care Stocks On The Rise With Help From 3 Stocks
at The Street - Tue Oct 28, 12:04PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
AMGN: 157.19 (+8.99), RCPT: 95.76 (+28.02), NVS: 92.35 (+2.14)

Receptos Soars After Lead Drug Racks Up Another Win
at Investor's Business Daily - Tue Oct 28, 10:46AM CDT
Receptos (RCPT) stock jumped more than 47% to a new high above 99 in morning trading on the stock market today, and the company got multiple price-target increases after its bowel-disease drug succeeded in a midstage trial. Receptos announced late...
JNJ: 104.79 (+0.72), RCPT: 95.76 (+28.02), ABBV: 60.93 (+0.44)

Stock Futures Positive, Steady; Vasco Rockets, Twitter Fades
at Investor's Business Daily - Tue Oct 28, 8:01AM CDT
Stock futures rolled up moderate gains ahead of Tuesday's open, as investors geared up for a session with many moving parts. Dow futures were steady, trading 73.1 points above fair market value. Nasdaq 100 futures were up a strong 19.4 points, and...
WHR: 168.06 (+10.66), VDSI: 23.73 (+5.44), RCPT: 95.76 (+28.02), BP: 42.84 (+0.89), TWTR: 43.78 (-4.78), AET: 77.23 (-1.95)

RECEPTOS
at Investor's Business Daily - Mon Oct 27, 5:48PM CDT
RECEPTOS (RCPT), a biotech, reported positive phase 2 trial results for its RPC1063 treatment for ulcerative colitis. Shares shot up 25.1% to 85.02.
RCPT: 95.76 (+28.02)

Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis
GlobeNewswire - Mon Oct 27, 3:01PM CDT
- Study met primary efficacy and all secondary endpoints with statistical significance for patients on 1 mg dose after 8 weeks of treatment -
RCPT: 95.76 (+28.02)

Surprising Stocks That Performed Best for Billionaires in 2014
at The Street - Mon Oct 27, 7:48AM CDT
See the stocks that have performed the best for 19 billionaires who made their money investing.
BDSI: 17.17 (+0.33), ATHL: 58.18 (+0.11), VIPS: 218.02 (+7.36), ARII: 73.24 (+5.53), SBAC: 113.06 (+0.75), BIOF: 7.28 (+0.01), BKW: 32.00 (-0.11), LUV: 34.53 (+0.48), HCA: 71.28 (-0.12), LPDX: 5.21 (+0.01), DTV: 84.01 (+0.02), RCPT: 95.76 (+28.02), WMB: 54.04 (+0.62), BRK.B: 140.46 (+0.93), BRK.A: 210,570.00 (+1,348.00), SBGL: 8.72 (+0.25), AN: 55.58 (+3.59)

Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody in Phase 2 Trial for Eosinophilic Esophagitis
GlobeNewswire - Fri Oct 03, 6:59AM CDT
Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that the first patient has been treated in a Phase 2 trial of RPC4046, Receptos' development candidate for eosinophilic esophagitis (EoE). RPC4046 is a humanized monoclonal antibody directed against interleukin-13 (IL-13), a target which has been validated in other related allergic indications.
RCPT: 95.76 (+28.02)

The 5 Best Biotech Stocks in 2014...so far
Todd Campbell, The Motley Fool - Motley Fool - Fri Sep 26, 7:35AM CDT
Since the quarter is wrapping up and investors are considering their game plan heading into year-end, let's look at biotech's biggest winners for the year, why they've rallied, and whether they make sense for your portfolio . Specifically, let's...
GILD: 113.45 (+0.86), ACHN: 11.94 (+0.17), RCPT: 95.76 (+28.02), PTCT: 41.30 (+3.67), ICPT: 246.59 (+3.50), PBYI: 252.89 (+7.64)

Critical Alerts For FuelCell Energy, Receptos Inc., HD Supply Holdings Inc., Westport Innovations and Organovo Released By InvestorsObserver
PR Newswire - Thu Sep 11, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for FCEL, RCPT, HDS, WPRT and ONVO.
WPRT: 6.28 (+0.46), FCEL: 1.80 (+0.06), ONVO: 6.48 (+0.47), HDS: 28.02 (+0.68), RCPT: 95.76 (+28.02)

Market Maker Surveillance Report. NPSP, CYTK, JDSU, INVT, MNDL, RCPT, Winning Stocks With Lowest Price Friction For Wednesday, September 10th 2014
M2 - Thu Sep 11, 4:12AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4911 companies with "abnormal" market making, 2481 companies with positive Friction Factors and 2383 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. NPS Pharmaceuticals Inc (NASDAQ:NPSP), Cytokinetics Inc (NASDAQ:CYTK), JDS UNIPHASE CORPORATION (NASDAQ:JDSU), INVESTAMERICA INC (OTC:INVT), Mandalay Digital Group Inc (OTC:MNDL), (NASDAQ:RCPT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
CYTK: 3.57 (+0.14), INVT: 1.33 (-0.05), RCPT: 95.76 (+28.02), JDSU: 12.46 (+0.28), NPSP: 28.12 (+0.80), MNDL: 3.83 (+0.07)

Good news for Receptos drug
at Investor's Business Daily - Wed Sep 10, 5:53PM CDT
The biotech's drug candidate RPC1063 reduces multiple-sclerosis relapses equally well as Novartis' (NVS) Gilenya, but with less risk of liver damage, according to results from a midstage clinical trial. Receptos (RCPT) already revealed its initial...
RCPT: 95.76 (+28.02), NVS: 92.35 (+2.14)

Why Receptos Inc. Shares Rocketed Higher
Sean Williams, The Motley Fool - Motley Fool - Wed Sep 10, 2:49PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Receptos , a clinical-stage...
BIIB: 318.03 (-1.95), RCPT: 95.76 (+28.02)

Stocks Hold Modest Gains; FleetCor Reverses Higher
at Investor's Business Daily - Wed Sep 10, 1:53PM CDT
Stocks held on to decent gains and were near session highs Wednesday, recovering nicely from Tuesday's bout of institutional selling. The Nasdaq outperformed, rising 0.6%. The Dow Jones industrial average and S&P 500 added 0.3% each. Volume on the...
RH: 78.26 (+1.37), EBAY: 51.20 (+0.01), RCPT: 95.76 (+28.02), FLT: 140.27 (+1.72), AAPL: 106.74 (+1.63), REGN: 397.89 (-9.27)

Stocks Turn Higher After Soft Start; U.S. Silica Jumps
at Investor's Business Daily - Wed Sep 10, 12:25PM CDT
Stocks turned higher in early afternoon trade Wednesday after a soft open. The Nasdaq led the way, rising 0.5%. The Dow Jones industrial average and S&P 500 added 0.1% each. Volume on the NYSE and Nasdaq was tracking 5% to 10% higher than Tuesday's...
RH: 78.26 (+1.37), BIIB: 318.03 (-1.95), GILD: 113.45 (+0.86), GMCR: 146.66 (+3.38), ALXN: 192.20 (+1.65), RCPT: 95.76 (+28.02), PANW: 105.41 (+1.74), SLCA: 49.54 (+1.94), REGN: 397.89 (-9.27)

Fraud Allegations Cause 21Vianet Group To Plunge
at The Street - Wed Sep 10, 12:24PM CDT
Receptos Inc (NASDAQ:RCPT), Senomyx Inc. (NASDAQ:SNMX) and Flexion Therapeutics Inc (NASDAQ:FLXN) climbed on Wall Street this morning. Taking notable dives are 21Vianet Group Inc (NASDAQ:VNET), Anglo...
VNET: 19.96 (+0.91), WUBA: 38.50 (+1.27), FLXN: 19.90 (+1.18), AU: 9.53 (+0.19), RCPT: 95.76 (+28.02), SNMX: 7.96 (+0.28)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

NYSE Texas Redefines the U.S. Capital Markets Landscape

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Charter Next Generation Unveils Gen 2 MDO-PE Films

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Navigating Holiday Sweets: Healthy Balancing Acts

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

JiMMYBAR! Expands Creatine Market with Target Launch

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Karoo Health Leaps Forward with New CCO Breton

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...